Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | 5.0 |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | 0.89 | 1.93 |
NAV | ₹10.44 | ₹424.48 |
Fund Started | 02 Jun 2025 | 04 Jun 1999 |
Fund Size | ₹14.43 Cr | ₹4130.76 Cr |
Exit Load | - | Exit load of 0.50% if redeemed within 15 days |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | - | -1.71% |
3 Year | - | 23.41% |
5 Year | - | 17.27% |
1 Year
3 Year
5 Year
Equity | 99.72% | 96.05% |
Cash | 0.28% | 3.88% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 19.16% |
Max Healthcare Institute Ltd. | 8.58% |
Cipla Ltd. | 8.55% |
Divi's Laboratories Ltd. | 8.17% |
Dr. Reddy's Laboratories Ltd. | 7.61% |
Apollo Hospitals Enterprise Ltd. | 7.36% |
Lupin Ltd. | 5.00% |
Fortis Healthcare Ltd. | 4.76% |
Laurus Labs Ltd. | 3.98% |
Torrent Pharmaceuticals Ltd. | 3.86% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.18% |
Divi's Laboratories Ltd. | 7.26% |
Max Healthcare Institute Ltd. | 5.62% |
Cipla Ltd. | 4.41% |
Lonza Group Ag | 4.05% |
Lupin Ltd. | 4.04% |
Acutaas Chemicals Ltd. | 3.81% |
Fortis Healthcare Ltd. | 3.76% |
Torrent Pharmaceuticals Ltd. | 3.49% |
Jupiter Life Line Hospitals Ltd. | 3.46% |
Name | Anil Ghelani | Tanmaya Desai |
Start Date | 24 Nov 2025 | 17 May 2024 |
Name
Start Date
Description | The scheme seeks to generate returns that are commensurate with the performance of the Nifty Healthcare Index, subject to tracking error. | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. |
Launch Date | 02 Jun 2025 | 04 Jun 1999 |
Description
Launch Date